Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis
- 31 August 2022
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 25 (10) , 1705-1716
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1Value in Health, 2012
- PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsValue in Health, 2011
- Valuing Condition-Specific Health States Using Simulation Contact LensesValue in Health, 2009
- Assessment of the Effect of Visual Impairment on Mortality through Multiple Health Pathways: Structural Equation ModelingInvestigative Ophthalmology & Visual Science, 2008
- Inflammatory cystoid macular edemaCurrent Opinion in Ophthalmology, 2007
- Impact of Macular Edema on Visual Acuity in UveitisOphthalmology, 2006
- Preference-Based EQ-5D Index Scores for Chronic Conditions in the United StatesMedical Decision Making, 2006
- Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International WorkshopAmerican Journal of Ophthalmology, 2005
- Impact of unilateral and bilateral vision loss on quality of lifeBritish Journal of Ophthalmology, 2005
- Causes and frequency of blindness in patients with intraocular inflammatory disease.British Journal of Ophthalmology, 1996